Fig. 3
From: Deficiency of peripheral CLA+ Tregs and clinical relevance in Behcet’s syndrome
Proportion of CLA+ Tregs among CD4+ T cells before and after treatment. The BDCAF scores of patients with BS decreased (pre-treatment: 4.0 (interquartile range: 2.25–4.75); post-treatment: 2.0 (interquartile range: 1.0–3.0)). The proportion of CLA + Tregs among CD4 + T cells was significantly higher after treatment with glucocorticoids or immunosuppressants than at baseline [1.04 (interquartile range: 0.76–1.35) vs. 1.56 (interquartile range: 1.20–1.74), P = 0.0121]